French nanomedicine company Nanobiotix on Tuesday said it has started exploring the use of its lead trial durg compound for combination in immuno oncology.
Source: Nanobiotix says initiating immuno-oncology research with lead product
French nanomedicine company Nanobiotix on Tuesday said it has started exploring the use of its lead trial durg compound for combination in immuno oncology.
Source: Nanobiotix says initiating immuno-oncology research with lead product